539997 KWALITY

Kwality Pharmaceuticals Share Price

 

 

Start SIP in KWALITY

Start SIP

Performance

  • Low
  • ₹1,094
  • High
  • ₹1,160
  • 52 Week Low
  • ₹596
  • 52 Week High
  • ₹1,235
  • Open Price₹1,094
  • Previous Close₹1,092
  • Volume143,386
  • 50 DMA₹1,012.22
  • 100 DMA₹983.25
  • 200 DMA₹943.04

Investment Returns

  • Over 1 Month + 26.51%
  • Over 3 Month + 28.93%
  • Over 6 Month -0.54%
  • Over 1 Year + 23.08%

Smart Investing Starts Here Start SIP with Kwality Pharmaceuticals for Steady Growth!

Invest Now

Kwality Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.1
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 1,180
  • P/B Ratio
  • 4.1
  • Average True Range
  • 60.22
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 49.9
  • RSI
  • 61.82
  • MFI
  • 74.97

Kwality Pharmaceuticals Financials

Kwality Pharmaceuticals Technicals

EMA & SMA

Current Price
₹1,137.55
+ 45.2 (4.14%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,077.47
  • 50 Day
  • ₹1,012.22
  • 100 Day
  • ₹983.25
  • 200 Day
  • ₹943.04

Resistance and Support

1135.63 Pivot Speed
  • R3 1,244.17
  • R2 1,202.08
  • R1 1,177.72
  • S1 1,111.27
  • S2 1,069.18
  • S3 1,044.82

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kwality Pharmaceuticals has an operating revenue of Rs. 422.61 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 15% is great, ROE of 15% is good. The company has a reasonable debt to equity of 6%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 14% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 84 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 69 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kwality Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-11 Quarterly Results
2025-05-19 Audited Results
2025-01-31 Quarterly Results
2024-10-30 Quarterly Results

Kwality Pharmaceuticals F&O

Kwality Pharmaceuticals Shareholding Pattern

54.83%
0%
33.67%
11.5%

About Kwality Pharmaceuticals

  • NSE Symbol
  • KWALITY
  • BSE Symbol
  • 539997
  • Managing Director
  • Mr. Ramesh Arora
  • ISIN
  • INE552U01010

Similar Stocks to Kwality Pharmaceuticals

Kwality Pharmaceuticals FAQs

Kwality Pharmaceuticals share price is ₹1,137 As on 10 January, 2026 | 10:10

The Market Cap of Kwality Pharmaceuticals is ₹1180.3 Cr As on 10 January, 2026 | 10:10

The P/E ratio of Kwality Pharmaceuticals is 24.1 As on 10 January, 2026 | 10:10

The PB ratio of Kwality Pharmaceuticals is 4.1 As on 10 January, 2026 | 10:10

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23